Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

AGE

AgeX Therapeutics (AGE)

AgeX Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:AGE
DateTimeSourceHeadlineSymbolCompany
23/03/202408:27GlobeNewswire Inc.AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
08/03/202408:49Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsAMEX:AGEAgeX Therapeutics Inc
08/03/202408:47Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
07/03/202423:47Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
15/02/202408:01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
14/02/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AGEAgeX Therapeutics Inc
07/02/202408:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
05/02/202423:19Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
20/01/202408:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
19/01/202409:29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:AGEAgeX Therapeutics Inc
18/01/202408:19Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
17/01/202401:11Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]AMEX:AGEAgeX Therapeutics Inc
12/01/202408:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
10/01/202408:16Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
06/01/202408:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
29/12/202308:02Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
19/12/202308:25Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
14/12/202309:11Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
09/12/202308:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
02/12/202308:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
18/11/202308:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
17/11/202308:01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
16/11/202301:38Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AGEAgeX Therapeutics Inc
15/11/202308:25Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
15/11/202308:05Business WireAgeX Therapeutics Reports Third Quarter 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
08/11/202308:06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:AGEAgeX Therapeutics Inc
08/11/202308:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AGEAgeX Therapeutics Inc
07/11/202308:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
02/11/202307:28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
07/10/202307:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
 Showing the most relevant articles for your search:AMEX:AGE